EPA issues, USDA amends respective biotech rules
نویسندگان
چکیده
منابع مشابه
SIMULATING BIOTECH MANUFACTURING OPERATIONS : ISSUES AND COMPLEXITIES Prasad
The Biotech industry is still an emerging application area for simulation techniques. This paper describes the hierarchical discrete event simulation efforts at Bayer Corporation’s Berkeley facility that manufactures secondgeneration recombinant DNA technology based drug, Kogenate-FS. The facility consists of multiple manufacturing areas housing state-of-the-art biotech processes. The main simu...
متن کاملBiotech Traits in Alfalfa – What’s Next?
In June 2005, USDA/FDA/EPA deregulated the Roundup Ready trait in alfalfa. In August 2005, seed of the first Roundup Ready alfalfa varieties was offered for sale. This was the first biotech trait to be commercialized in alfalfa, and paved the way for new research supporting a second wave of biotech traits enhancing value in alfalfa. These new biotech traits can be divided into two categories: o...
متن کاملActionable Rules: Issues and New Directions
Knowledge Discovery in Databases (KDD) is the process of extracting previously unknown, hidden and interesting patterns from a huge amount of data stored in databases. Data mining is a stage of the KDD process that aims at selecting and applying a particular data mining algorithm to extract an interesting and useful knowledge. It is highly expected that data mining methods will find interesting...
متن کاملQuestionnaire for a Biotech
How and when did your company start, and where are you located? NovaDigm was founded in 2005 by a group of investigators at the los Angeles Biomedical research institute (lA BioMed) and the Division of infectious Diseases at Harbor-UclA Medical center. The company received its first venture capital funding from Domain Associates in 2008 and established its corporate headquarters and laboratory ...
متن کاملBiotech Funding Trends
This is a must-have resource for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 1997
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt0697-503